Tricia Haugeto

Tricia Haugeto

Health Technology

Profile

Tricia Haugeto worked as a Director of Corporate Communications & Investor at Array BioPharma, Inc. from 2013 to 2019.

Former positions of Tricia Haugeto

CompaniesPositionEnd
ARRAY TECHNOLOGIES, INC. Investor Relations Contact 31/12/2018
See the detail of Tricia Haugeto's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tricia Haugeto's experience

Linked companies

Private companies1
Array BioPharma, Inc.
Logo Array BioPharma, Inc.

Array BioPharma, Inc.

Pharmaceuticals: MajorHealth Technology

Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO.

Health Technology

  1. Stock Market
  2. Insiders
  3. Tricia Haugeto